These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21850396)

  • 1. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
    Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
    Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
    Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
    J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
    Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
    Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
    Anderson WF; Chu KC; Chang S
    J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
    Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
    Gudina AT; Copeland G; Soliman AS; Hirko KA
    Breast Cancer Res Treat; 2019 Feb; 173(3):693-699. PubMed ID: 30406365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
    Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
    Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
    Chang S; Parker SL; Pham T; Buzdar AU; Hursting SD
    Cancer; 1998 Jun; 82(12):2366-72. PubMed ID: 9635529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
    van Uden DJ; Bretveld R; Siesling S; de Wilt JH; Blanken-Peeters CF
    Breast Cancer Res Treat; 2017 Apr; 162(2):365-374. PubMed ID: 28138891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
    Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
    Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of inflammatory breast cancer in women, 1992-2009, United States.
    Goldner B; Behrendt CE; Schoellhammer HF; Lee B; Chen SL
    Ann Surg Oncol; 2014 Apr; 21(4):1267-70. PubMed ID: 24366421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
    Aurit SJ; Devesa SS; Soliman AS; Schairer C
    Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
    Hausauer AK; Keegan TH; Chang ET; Clarke CA
    Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
    Abraham HG; Xia Y; Mukherjee B; Merajver SD
    Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.
    Schlichting JA; Soliman AS; Schairer C; Banerjee M; Rozek LS; Schottenfeld D; Harford JB; Merajver SD
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):155-65. PubMed ID: 22028401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 (IL-18) is equally expressed in inflammatory breast cancer and noninflammatory locally advanced breast cancer: A possible association with chemotherapy response.
    Aguiar MAN; Wanderley CWS; Nobre LMS; Alencar MRM; Saldanha MDPS; Souza AM; Wong DVT; Barros PG; Almeida PRC; Lima-Júnior RCP; Ribeiro RA
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e138-e144. PubMed ID: 28766916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for inflammatory breast cancer and other invasive breast cancers.
    Schairer C; Li Y; Frawley P; Graubard BI; Wellman RD; Buist DS; Kerlikowske K; Onega TL; Anderson WF; Miglioretti DL
    J Natl Cancer Inst; 2013 Sep; 105(18):1373-84. PubMed ID: 24046390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.